Next Article in Journal
Synthesis of Epoxy Methacrylate Resin and Coatings Preparation by Cationic and Radical Photocrosslinking
Next Article in Special Issue
Oxidative Crosslinking of Peptides and Proteins: Mechanisms of Formation, Detection, Characterization and Quantification
Previous Article in Journal
Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach
Previous Article in Special Issue
The Time Scale of Electronic Resonance in Oxidized DNA as Modulated by Solvent Response: An MD/QM-MM Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 26
Issue 24
10.3390/molecules26247664
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Direct and Indirect Chemiluminescence: Reactions, Mechanisms and Challenges

by
Marina A. Tzani
1,
Dimitra K. Gioftsidou
1,
Michael G. Kallitsakis
1,
Nikolaos V. Pliatsios
1,
Natasa P. Kalogiouri
1,
Panagiotis A. Angaridis
1,
Ioannis N. Lykakis
1,* and
Michael A. Terzidis
2,*
1
Department of Chemistry, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece
2
Department of Nutritional Sciences and Dietetics, International Hellenic University, Sindos Campus, 57400 Thessaloniki, Greece
*
Authors to whom correspondence should be addressed.
Molecules 2021, 26(24), 7664; https://doi.org/10.3390/molecules26247664
Submission received: 24 November 2021 / Revised: 12 December 2021 / Accepted: 14 December 2021 / Published: 17 December 2021
(This article belongs to the Special Issue Biomimetic Radical Chemistry and Applications 2021)
Browse Figures
Versions Notes

Abstract

:
Emission of light by matter can occur through a variety of mechanisms. When it results from an electronically excited state of a species produced by a chemical reaction, it is called chemiluminescence (CL). The phenomenon can take place both in natural and artificial chemical systems and it has been utilized in a variety of applications. In this review, we aim to revisit some of the latest CL applications based on direct and indirect production modes. The characteristics of the chemical reactions and the underpinning CL mechanisms are thoroughly discussed in view of studies from the very recent bibliography. Different methodologies aiming at higher CL efficiencies are summarized and presented in detail, including CL type and scaffolds used in each study. The CL role in the development of efficient therapeutic platforms is also discussed in relation to the Reactive Oxygen Species (ROS) and singlet oxygen (1O2) produced, as final products. Moreover, recent research results from our team are included regarding the behavior of commonly used photosensitizers upon chemical activation under CL conditions. The CL prospects in imaging, biomimetic organic and radical chemistry, and therapeutics are critically presented in respect to the persisting challenges and limitations of the existing strategies to date.

Graphical Abstract

1. Introduction

Chemiluminescence (CL) is the spontaneous emission of light from an electronically excited state of a species produced by a chemical reaction [1]. Nature uses CL (called bioluminescence) in many living organisms such as fireflies, mushrooms, shells, jellyfish, [2] worms and bacteria, mainly for communication or defense roles [3]. In biological systems, bioluminescence occurs from in situ enzyme-catalyzed chemical transformations, for example luciferin [4] reacts with oxygen in the presence of luciferase enzyme [5], magnesium [6,7,8,9] or calcium ions and adenosine triphosphate (ATP), leading to luminescence [10,11,12]. The reaction involves chemical activation of specific molecules (A) via oxidation, resulting in a chemiexcited intermediate (CEI) (C* or D*; excited species indicated by *) that releases its energy either via light emission (direct) or by transferring it, through a chemiluminescence resonance energy transfer (CRET) process, to an adjacent fluorophore (E) that becomes excited (E*); this fluorophore subsequently releases part of its energy by emitting light. These two distinct mechanisms dictate the two types of CL, direct and indirect, respectively, as shown in Figure 1.
Typical examples of molecules that emit light via direct CL are luminol and luciferin, two of the most well-studied luminogenic substances which are susceptible to oxidation by hydrogen peroxide (H2O2) and superoxide radical anion (O2●–). The emitted light is the result of changes in the chemical structure of the produced chemiexcited intermediates. Under certain conditions, singlet oxygen (1O2) can also be produced at high amounts, as chemiexcitation product, by peroxides via direct CL. 1O2 upon radiative relaxation emits infrared light at 1270 nm if not previously trapped, affording oxidation products [13]. The production of 1O2 under CL conditions is discussed later in the text (vide infra). In addition, oxalate esters and 1,2-dioxetane derivates serve as efficient precursors both for direct and indirect CL providing tunable emission systems depending on the photophysical properties of the energy acceptor fluorophore, with a wide range of applications in sensing and diagnosis, molecular imaging, and cancer treatment [14,15].
In indirect CL, energy transfer takes place, resulting in excitation of a fluorophore or a photosensitizer that can further act independently. In the presence of molecular oxygen (O2), the photosensitizer can generate reactive oxygen species (ROS) such as O2●–, hydroxyl radicals (HO●) or 1O2. These species have a broad spectrum of reactivity with biomolecules [16,17,18,19] and can be used in photodynamic therapy (PDT) to induce selectively cancer cell death, as well as other chemical transformations [20,21,22,23].
Most of the studied CL systems exhibit flash-type single-color light emissions that usually limit their applications. Long-lasting multicolor CL in aqueous solutions is highly desirable, especially in biological applications, however a controllable chemical procedure still remains a challenge. CL is a powerful tool in analytical chemistry that is used for the detection and quantification of reactive oxygen and nitrogen species [24,25], and numerous biological materials such as DNA [26], RNA [27], proteins [28], microorganisms, cells, metals [14,29], etc. [30,31]. Lately, immunoassays have been also used for the detection of SARS-CoV-2 [32].
Moreover, CL has been considered as an alternative photo-uncaging option in drug-delivery technologies for meeting the increasing demand for efficient strategies [15]. However, in biological systems, several issues have to be addressed, such as: (i) the tissue penetration of the incident light used for photoactivation of the emitted photons represents one of major barriers limiting efficiency in imaging or other applications, (ii) light can be scattered or absorbed by other biomolecules inside the cell, and (iii) light intensity is inversely proportional to the square of the distance from the light source, in this way causing weak interaction between an incident photon and a molecule (see Jablonski energy diagram, Figure 2) which leads to poor photochemical interactions. CL has increasingly attracted the interest of the research community, providing solutions to persisting problems of typical photochemical procedures. Recent successful examples from imaging and therapeutics fields highlight the great potential of CL-induced applications. To date, the reported reviews discuss CL mainly focused on chemiluminescent molecules such as luminol, cypridina luciferin and peroxyoxalates or analogues that can be used in sensing, imagine and therapeutic applications [33,34,35,36].
The aim of this review is to provide a summary of the recent developments in this field, based on direct and indirect CL. An overview of the strategies leading to better analytical sensitivity is included along with recent indicative examples. The role of 1O2 as a chemiexcitation product is also described in relation to the application and further development of more efficient CL-induced therapeutic platforms. Finally, unpublished results of our research regarding the behavior of commonly used photosensitizers as energy acceptors under CL conditions are also included together with discussion on the prospects and the challenges of CL applications in imaging, biomimetic organic and radical chemistry, and therapeutics.

2. Mechanistic Aspects of the Types of Chemiluminescence: Direct and Indirect

Among the different types of luminescence, the most typical ones are photoluminescence (PL), chemiluminescence (CL), bioluminescence (BL), and electrochemiluminescence (ECL). A list of recent references for each luminescence type is provided in Table 1.
In PL, incident photons are the driving force for the emission of light by a molecule. Upon absorption of a photon of a particular energy, the molecule becomes photoexcited to an electronically excited state (Figure 2). Among the various paths that can be followed to dissipate the excess energy, radiative relaxation can occur via phosphorescence (T1→S0) or fluorescence (S1→S0).
Electrochemiluminescence (ECL) is the production of light by an excited species that has been generated electrochemically, i.e., an electron transfer reaction at the surface of an electrode (Figure 3). Numerous review articles and monographs are found in the literature to date on the electrogenerated CL, describing the fundamentals, mechanisms and applications. Thus, in this review we will not further discuss this type of CL [42].
In bioluminescence (BL), which is naturally occurring CL, light is emitted by live organisms. Various luminophore molecules, enzymes and cofactors are involved in the more than 30 different bioluminescent systems known to date [40]. As was mentioned before, CL is a process in which chemical reactions can generate an excited intermediate who can emit light directly—direct emission—or transfer its energy to an acceptor fluorophore—indirect emission—(Figure 1). The FRET (Förster Resonance Energy Transfer or Fluorescence Resonance Energy Transfer), which refers to the nonradiative transfer of energy from an excited donor to an acceptor mediated by electronic dipole–dipole coupling, between the oxidized CL reagent (excited state donor) and a fluorophore (acceptor) is referred as chemiluminescence resonance energy transfer (CRET). Apart from bioimaging and sensing applications, recent advances in the PDT field revealed that CL could act as an alternative to conventional light sources. The proximity of the light source to the “target” molecule, as is the case for CL, assists the photochemical transformations to progress faster and photon flux requirements are lower in respect to the procedures based on conventional type of light sources [41].

3. Direct Chemiluminescence

To the best of our knowledge, one of the very first examples of direct CL is dated back in 1928 [43], and it is based on the oxidation of luminol by H2O2 (Scheme 1) [44,45]. After luminol’s oxidation, a strong blue emission with λmax = 425 nm is recorded through a reverse intersystem crossing (rISC) [46,47,48] that can last from a second up to few hours, depending on the quantity of the reacting species, the presence of specific additives and the “feeding” process. The light emission of luminol and its derivatives can be assisted by catalysts such as peroxidase and heme, which are usually used as additives. For example, horseradish peroxidase (HRP) is involved in the production of a luminol free radical by two molecules of luminol anion [49].
Similarly to luminol, cypridina luciferin emits blue light after oxidation by molecular oxygen catalyzed by cypridina luciferase (Scheme 2) [50,51,52]. Moreover, emission was also recorded after oxidation of 2-methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-3-one, a cypridina luciferin analogue, by O2●–. At the time of its discovery, this selective oxidation provided a unique opportunity for direct CL detection of O2●– and further development of other similar chemiluminescent probes [6].
A D-luciferin hydrazine analogue has been synthesized for the selective imaging of Cu2+. The CL reaction relies on the catalytic transformation of hydrazide analogue to D-luciferin that is further converted to oxyluciferin by luciferase in the presence of ATP and Mg2+ (Scheme 3) [53].
Besides the commonly used luminol and cypridina luciferin scaffolds, other compounds such as peroxyoxalates, dioxetane, acridinium and chromone derivatives were also developed and have been used lately as efficient, direct CL reagents in various applications. A summary of recent direct CL applications is provided in Table 2 along with details on the system and the scaffold used.

3.1. Direct Chemiluminescence by Luminol and Its Derivatives

In aqueous luminol solutions, H2O2 usually acts as an oxidant causing CL. However, luminol can also be oxidized catalytically by ozone, 1O2, and hypochlorites in the presence of various transition metal ions. In contrast, in aprotic solvents (i.e., DMSO) luminol’s CL depends on the pH (basic conditions are required) and the presence of O2. Recently, it was proposed that the decomposition of the dianionic cyclic peroxide intermediate (CP2−), i.e., 1,2-dioxane-3,6-dione dianion, causes the chemiexcitation of luminol, as shown in Scheme 4. Computational studies have supported a stepwise single-electron transfer (SET) from the amino-phthaloyl to the O−O bond, initiating the decomposition of CP2− [65].
It is also reported that luminol CL could be significantly enhanced in the presence of hydroxylated intermediates generated by persulfate-based advanced oxidation processes (AOPs) of 1,2-divinylbenzene (DVB). Since the emission of light found to be dependent on the oxidation efficiency of the recalcitrant pollutants, luminol CL was proposed (Figure 4) for tracking a wider range of hydroxylated intermediates generated during persulfate-based AOPs under different degradation conditions, and other relevant organic compounds [55].
In most cases, where transition metals are involved, metal-peroxide complexes and metal-luminol or metal-luminol-O2 intermediates (M-LHOOH) are formed, which are believed to be the key intermediates for the CL of luminol-based systems (Scheme 5) [65].
Cobalt-doped hydroxyapatite nanoparticles (CoHA-NPs) have been reported to enhance luminol CL intensity by more than 75 times compared to the conventional luminol-H2O2 system. During investigations on the impact of CoHA-NPs sizes, composition, and crystallinity on the CL intensity, it was found that the maximum CL intensity is achieved by polycrystalline NPs, owing to their larger surface area. The proposed mechanism involves the ionization of H2O2 under basic conditions, leading to the formation of hydroperoxide-anions, which subsequently interact with the Co atoms on the NPs surface, forming the metal-hydroperoxide intermediate. The peroxyl radicals, after decomposition of the intermediate, are degraded into HO•, which ultimately oxidizes luminol leading to the chemiexcited intermediate (Figure 5) [56].
A new artificial heme-enzyme, so-called FeMC6*a [57], was also found to enhance luminol CL emission signal in comparison to the horseradish peroxidase (HRP)-based sensors (Figure 6), when used in a H2O2-detecting bioassay [49,66,67,68,69,70,71].
The catalytic activity of Cu-metal-organic frameworks (Cu-MOFs) with flower morphology, obtained from Cu-based metal-organic gels, was reported to promote persistent CL in luminol–H2O2 systems. According to the proposed mechanism, luminol’s CL was attributed to the gradual generation of HO•, O2•‾ and 1O2 species (Figure 7) and recombination of HO• and O2•‾ into 1O2 on the surface of Cu-MOFs, which also resulted in prolonged CL [58].
Recently, it was also reported that luminol’s CL efficiency can be tuned by manipulating the electronic properties of the aromatic ring via substitution, with the 8-methyl substituent providing the highest ΦCL enhancement (Figure 8). In silico studies revealed that the 8-substitution assists the cleavage of the O-O bond via the negative charge donation to the in situ formed peroxide [72]. Previous studies on the factors that could possibly influence luminol’s CL indicated that both steric and electronic effects play a significant role [73].

3.2. Direct Chemiluminescence from Probes Other Than Luminol

Apart from luminol derivatives, isoluminol [73], pyridopyridazines and phthalhydrazides [59] that were studied and used as CL probes [74], other molecules have been also designed and used in various CL applications which are not based on luminol’s chemical structure. J. Yang and coworkers reported the synthesis and validation of a new CL molecule, so-called ADLumin-1, as a turn-on probe for amyloid beta (Aβ) species with maximum emission at 590 nm. This probe was then found that can be used in indirect CL via CRET to a curcumin-based NIR fluorescent imaging probe, so-called CRANAD-3, thus more information will be provided in the section on indirect CL (vide infra) [60].
Peroxyoxalate chemiluminescence (PO-CL) is one of three most common CL reactions [75]. It is a base-catalyzed reaction of an aromatic oxalic ester with H2O2 in the presence of a fluorophore, also commonly referred to as activator (ACT) [76]. When ACT interacts with the in situ-generated high-energy intermediate (HEI), usually a 1,2-dioxetanedione, light emission occurs. The process relies on the reaction between the diphenyloxalate and H2O2 that generates 1,2-dioxetanedione [77] which spontaneously decomposes to carbon dioxide via a paramagnetic oxalate biradical intermediate [78,79]. Several catalysts have been proposed so far, with imidazole being the most commonly used one [80]. Imidazole acts as a nucleophilic and base catalyst at different reaction steps [81]. Apart from imidazole, only few catalysts appear to work efficiently, and among them are: sodium salicylate, 4-N,N-dimethylaminopyridine and its derivatives, and a mixture of 1,2,4-triazole and 1,2,2,6,6-pentamethylpiperidine [82,83]. Cabello et al., working on the kinetics of the PO-CL, used three oxalic esters of diverse reactivity (e.g., bis(2,4,6-trichlorophenyl) oxalate (TCPO), bis(4-methylphenyl)oxalate (BMePO), bis[2-(methoxycarbonyl)-phenyl]oxalate (DMO)). The mechanistic studies performed in the presence of sodium salicylate in partially aqueous medium showed that the reaction rate constants were determined by H2O2 and sodium salicylate amounts (Scheme 6). Further studies showed that by increasing the salicylate concentration there is a decrease in the CL efficiency, probably due to the interaction between salicylate and the in situ-produced HEI. From experiments using different oxalic esters, a variation in the CL emission was reported, with DMO showing the highest quantum yields in the aqueous medium used (1:1 v/v of DME/H2O) [84].
When 2,6-lutidine was used as a non-nucleophilic base catalyst on the TCPO CL reaction, it was found that the concentrations of 2,6-lutidine and H2O2 play a crucial role in the rate-determining step. The reaction was found to follow a general base catalysis mechanism (Scheme 7) [85].
Among other CL molecules of interest are the 1,10-phenanthroline dioxetanes, generated after treatment of 1,10-phenanthroline with IO4− in the presence of H2O2. It has been reported that 1,10-phenanthroline dioxetanes enhance light emission in respect to the IO4−-H2O2 system alone. The proposed radical-based mechanism involves the C5=C6 bond of 1,10-phenanthroline that is initially attacked by HO•, leading to a dioxetane intermediate responsible for the CL emission (Scheme 8) [86]. The CL of the IO4−/peroxide system and the factors influencing the emission have been recently reviewed elsewhere [87].
Investigation into the CL efficiency of four bicyclic dioxetanes bearing 2-hydroxybiphenyl-4-yl (a), 2-hydroxy-p-terphenyl-4-yl (b), 2-hydroxy-p-quaterphenyl-4-yl (c), or 2-hydroxy-p-quinquephenyl-4-yl (d) (Figure 9) moieties, showed that a-c emit light from 466 nm to 547 nm during their decomposition while d was found to emit light of much weaker intensity from 490 nm up to 607 nm, depending on the solvent (water, acetonitrile or DMSO). The CL efficiencies of the latter dioxetanes in aqueous media were found to be enhanced in the presence of additives such as β-MCD (β-methylated cyclodextrin) or TBHP (tributylhexadecylphosphonium bromide) [88].
M. Yang et al. constructed a NIR chemiluminescent probe by caging the precursor of Schaap’s dioxetane scaffold and a dicyanomethylchromone acceptor for selective 1O2 detection. In the presence of 1O2, the probe is oxidized, affording the phenol-dioxetane moiety which undergoes spontaneous bond cleavage leading to the formation of the chemiexcited product responsible for the CL emission (Figure 10). With this probe, they were able to detect 1O2 in vitro with a turn-on bathochromic CL signal in the NIR region at 700 nm and image intracellular 1O2 produced by a photosensitizer under simulated photodynamic therapy conditions [54]. Similarly, hyperconjugated push-pull dicyanomethylchromone systems were used for the in vivo detection of H2O2 and β-galactosidase activity [61].
The CL emission mechanism proposed for the Schaap’s dioxetane probes [89,90,91], involves Chemically Initiated Electron Exchange Luminescence (CIEEL) [1,92] with a solvent-cage back electron-transfer step, which affords the 2-adamantanone and the chemiexcited phenolate that is responsible for the light emission (Scheme 9) [92,93].
Recently, modified ortho-nitrobenzyl and spiropyran 1,2-dioxetane probes have been synthesized and studied towards photoactivation by 254 nm or 365 nm photons. Irradiation of ortho-nitrobenzyl 1,2-dioxetanes with 254 nm light resulted in the formation of the chemiexcited phenolate after deprotection, while the spiropyran 1,2-dioxetane irradiation at λ = 254 nm afforded the open merocyanine chromophore intermediate that was finally converted to the corresponding excited phenolate with maximum emission at 500 nm. This open merocyanine intermediate was able to act as a photoswitch, thus it could return to its spiropyran form under white light irradiation subsequently after UV light irradiation (Scheme 10) [94].
Shabat and coworkers described the development of functional self-immolative molecular scaffolds based on Schaap’s dioxetane probes, and described their use in signal amplification and real-time monitoring of enzymatic activity or drug release. The general mode of action involves a triggering event for releasing a chemiexcited product, the CL reporter unit, and the payload which can be a reagent molecule, a drug or a prodrug. This strategy was used successfully in monitored release of the cytotoxic agent monomethyl auristatin E (MMAE) from prodrug Gal-A-Pept (Scheme 11). The prodrug is initially recognized by a β-galactosidase, releasing intermediate A-Pept which undergoes 1,6-elimination to afford the MMAE drug and quinone-methide A. Then, intermediate B is produced by the reaction of A with H2O, subsequently releasing 2-adamantanone and the chemiexcited phenolate C*. Green emission at 550 nm is observed due to radiative decay of the phenolate to the ground state [62].
Carbapenemase-producing organisms (CPOs) pose a severe threat to antibacterial treatments due to the acquisition of antibiotic resistance. Recently, Das et al. demonstrated the first carbapenemase CL probe (CPCL) for the detection of carbapenemase and CPOs. The unique structural design of CPCL enables the probe to rapidly disassemble via an efficient 1,8-elimination process upon hydrolysis of the β-lactam ring by a carbapenemase (Figure 11). This process results in the release of a chemiexcited phenolate that undergoes radiative relaxation, producing photons at 540 nm that enable a rapid and selective detection of carbapenemase activity [63].
The same as above reporter for monitoring carbapenemase activity CL was also used for detection of prostate-specific antigen (PSA) enzymatic activity by using artificial metalloenzymes (ArMs). The probe activation mechanism is based on a catalytic cleavage of a specific peptidyl substrate, followed by a release of a phenoxy-dioxetane intermediate affording a chemiexcited benzoate that emits a green photon. The benefit and simplicity of a CL assay to detect seminal fluid was effectively demonstrated by on-site measurements using a small portable luminometer [64].
Other efficient CL molecules are based on acridinium ester dyes analogues. The acridan dyes are quaternary acridine derivatives that become luminescent directly after their activation [95,96,97,98,99,100]. The mechanism of CL involving a dioxetane intermediate was first introduced by McCapra (Scheme 12) [101,102]. The simplicity of their synthesis and the high quantum yield (up to ca. 7%) [102], together with their ability to become oxidized under alkaline conditions, making acridinium derivatives highly suitable for sensing and chemiluminometric analysis [95,103]. Research on the design of new acridinium derivatives with even higher activity is an ongoing process [104].
Acridine-9-carboxylate derivatives [e.g., (4-(methoxycarbonyl)phenyl-10-methyl-10λ4-2,7-dimethyl-acridine-9-carboxylates)] were used for studying the CL efficiency in the 7–10 pH range. Reactions of acridine-9-carboxylates with H2O2 result in the formation of a relatively unstable dioxetanone intermediates. The chemiexcited methyl-acridone products formed after the decomposition of the dioxetanone intermediates are responsible for light emission. Among the compounds studied, 4-(methoxycarbonyl)phenyl- derivative gave the highest CL intensities at pH 7−10, indicating that the introduction of electron-donating groups at the 2,7-positions on the acridine moiety plays a crucial role in the whole process (Scheme 13) [105].

4. Indirect Chemiluminescence

In the indirect CL process, energy is transferred by the chemiexcited molecule (energy donor, D) to a second molecule (acceptor, E), which is further excited during the process. In the resonance excitation transfer mechanism, D and E are not in contact and may be separated by as much as 10 nm, although 1 nm or smaller transfer distances are more convenient. Except for distance, other factors dictating the energy transfer include the lifetime of the excited state of D and the degree of the overlap between the emission spectrum of D and the absorption spectrum of E. Usually, the higher overlapping the more efficient the energy transfer from D to E. The solvent is another crucial factor for the energy transfer between D and E molecules, however this effect includes a lot of specific characteristics properties of each system, such as the solvent cage factor. The short-range energy transfer by the wavefunction overlap between the donor and the acceptor, meaning overlap between the electronic clouds, is also a crucial factor. Particularly, both the Förster Resonance Energy Transfer or Fluorescence Resonance Energy Transfer (FRET) and Dexter Energy Transfer, with the second occurring when the D–E wavefunctions overlap, contribute to the energy transfer of the system, promoting its scope. FRET, which refers to the nonradiative energy transfer from an excited donor to an acceptor mediated by electronic dipole–dipole coupling, between a CL reagent as the excited donor and a fluorophore acceptor, is referred to as chemiluminescence resonance energy transfer (CRET) [106].
Two different modes of indirect CL emission can be distinguished, intermolecular and intramolecular CL, as shown in a simplified manner in Scheme 14A,B, respectively. After the triggering event, chemiexcited D is formed and then its energy is transferred to E, e.g., a photosensitizer (PS). When E is not directly linked with the chemiexcited species (Scheme 14A), the intermolecular distance between D and E (photosensitizer) plays crucial role in the energy transfer, with a direct emission (“escaping” photons) taking place together with the secondary emission. Sometimes this mode of action is crucial for distinguishing the two different events and their efficacy rate: one of the initial CL emission (direct emission) and the second is processed from the excited acceptor properties (Scheme 14A, secondary emission). On the other hand, in the case of an intramolecular system, the chemiexcited donor (D) is linked with the energy acceptor molecule (E) and a secondary emission pathway is favored (Scheme 14B).
The absorbance band of conventional photosensitizers such as Rose Bengal and TetraPhenylPorphyrin (TPP) (Type II photosensitizers) [107,108,109,110], as well as W10O324− (Type I’ photocatalyst) [111,112,113], fit well into the requirements for efficient CRET and high CL emissions [114]. Quantum Dots (QDs) have been also used successfully in various CRET studies. QDs are luminescent semiconductor nanocrystals with very distinct, size-dependent physicochemical behavior [106]. It should be noted that the excited photosensitizer or QDs can trigger various reaction cascades. For example, in the presence of molecular oxygen they can result in the production of ROS (e.g., 1O2, HO●, O2●−). This function is used in CL-induced photodynamic therapies and is described later in the text in more details (vide infra) [115].
A summary of recent direct CL scaffolds, systems and their applications are provided in Table 3 and Table 4, based on intra- and inter-molecular modes of reaction.

4.1. Intermolecular Chemiluminescence Emission Mode

J. Yang and coworkers, as mentioned above (vide supra), reported on the ADLumin-1 probe for Aβ species (Figure 12). To overcome problems related to short emission of ADLumin-1 they used the CRET strategy for transferring the energy to CRANAD-3, a curcumin-based, NIR fluorescent imaging probe emitting in the near-infrared region, at 730 nm (vide supra) [60].
Spiroadamantane 1,2-dioxetanes have been used in CL assay for in vivo visualization of β-galactosidase enzymatic activity in transgenic mice. For achieving this, an accelerant (diethanolamine in buffer containing EmeraldTM enhancer, T2081) was administered along with the β-D-galactopyranoside trigger (3-chloro-5-(5′-chloro-4-methoxyspiro[1,2-dioxetane-3,2′-tricyclo[3.3.1.13,7]decan]-4-yl)phenyl β-D-galacto pyranoside Galacton Plus). Thus, the energy was transferred by the produced chemiexcited intermediate to the EmeraldTM accelerant, causing emission at 540 nm (Figure 13) [120].
Other modified 1,2-dioxetane probes were also synthesized and used for in vivo imaging of hydrogen sulfide (H2S). The reduction of the azide on the para-azidobenzyl carbonate moiety triggered the self-immolative cleavage, affording the chemiexcited phenolate. Then, the energy transfer via CRET to the Emerald IITM CL enhancer [121] allowed detection at 545 nm (Figure 14) [122].
Another important study by Lipper et al., described that CL energy transfer from Schaap’s dioxetane probe can be efficiently used for ratiometric pH imaging. Their approach was based on energy transfer after the emission of phenolate during radiative relaxation to the pH-sensitive dye carboxy-SNARF-1 in CL-enhancer solutions, providing thee relative intensities at 535 nm, 585 nm and 650 nm due to relaxation of the protonated and deprotonated dye, respectively (Figure 15) [116].
Recently, a supramolecular strategy was reported, achieving a highly efficient CL-initiated cascade FRET by following a three-criteria rule: (i) D emission and the E absorption spectral overlapping; (ii) 10 nm or less as the D–E distance; and (iii) orientation of the D and E dipoles (see also Scheme 14). For this purpose, a nanoassemble β-cyclodextrin (β-CD) was used in an aqueous luminol/H2O2 solution in the presence of various fluorophores, which enable an accelerated multicolor CL with flexible emission wavelength in the range of 410–610 nm. Hydroxypropyl methylcellulose was utilized to slow down the diffusion rate, while the reaction was buffered by addition of solid Ca(OH)2. Moreover, it was found that Co2+-chitosan increased the CL emission of the system when merged with the β-CD nanoassembly system [126].
Another interesting CL system of cyclic peroxides was catalytically produced by tetrahydrofuran hydrogen peroxide in the presence of BSA-stabilized Gold Nanoclusters (Au@BSA NCs). Gold nanoclusters were found to accelerate the decomposition of the THF-hydroperoxides and promoted CRET between the chemiexcited dioxetane derivatives and the Au@BSA NCs (Figure 16). The CL emission (λmax = 650 nm) was found to be further enhanced by the presence of copper ions [127].
From the investigation into the CL behavior of an amphiphilic conjugate (defined as CLP) NPs, it was revealed that the NPs consisting of chlorine6 (Ce6), conjugated with luminol and polyethylene glycol undergo CRET with energy transfer to Ce6 upon triggering with H2O2. The CLP NPs were tested in cancer cells with high expression of H2O2 and monitored at 660–740 nm. In addition, excited Ce6 was capable of producing 1O2 in situ PDT against H2O2-high tumors, inhibiting lung metastasis. In vitro and in vivo experiments showed that CLP NPs could be a promising system in nanotheranostics, providing imaging and therapy, simultaneously, particularly in tumors with high levels of H2O2 [128].
Black Phosphorene (BP) QDs were initially studied in CL experiments upon reaction with H2O2 and HClO by Y. Lv and coworkers [129]. The same group two years later reported on the extension of the study with NH2-functionalized BP QDs (N-BPQDs) and showed that surface modification dictates the energy gap and electron mobility, thus favoring CL emission at 500 nm after triggering by persulfates [130].
Luminol’s analogue, L012, that shows 100 times higher than luminol CL intensity after oxidation by H2O2 at pH 7, was also used as a CRET donor. In vitro and in vivo studies with polyenthylene(glycol)-coated CdSeTe core QDs, used as energy acceptors, demonstrated that they can image H2O2 in live cells, pointing out the high potential of the system in the diagnosis of H2O2-associated diseases. The chemiexcited QDs were able to emit light at 780 nm, thus allowing monitoring [117].
The same luminol analogue L012 and H2O2 were recently studied in the presence of Fe(III) deuteroporphyrin IX chloride-polymer dots (FeDP-Pdots) as CL catalysts towards cancer therapy, providing high concentrations of ROS due to high CRET efficiency (Figure 17) [118].
CL has been also used in polymerization reactions. Linear polymer chains were synthesized along with cross-linked functional polymeric networks as a result of CL photoinitiated cationic polymerization based on a sulfonium salt (Figure 18). The polymerization reaction initiated CL emission at 430 nm. The photoinitiator decomposition after excitation produced protonic acids that were capable of initiating cationic polymerization of oxirane (epoxides) and vinyl monomers. The presence of iodonium salt in the initiating system was found to increase the polymerization efficiency [119].

4.2. Intramolecular Chemiluminescence Emission Mode

An intramolecular CRET approach based on chemically initiated electron exchange luminescence (CIEEL) has been recently adapted, while developing the first single molecule ratiometric CL probe for imaging pH in live animals. The proposed direct–indirect emission hybrid methodology, with emissions at 530 nm and 580 nm, relies on an acrylamide 1,2-dioxetane scaffold linked via a piperazine linker to a pH-sensitive carbofluorescein. This methodology withholds many characteristics that make it suitable for applications in quantifications of other important analytes produced in vivo (Figure 19) [123].
Teranishi proposed a cypridina luciferin analogue for detecting O2•− via intramolecular CRET to sulforhodamine 101. The energy transfer from the oxidized imidazopyrazinone to the acceptor dye results in light emission at 610 nm (Scheme 15). A similar approach was studied earlier with fluorescein analogue FCLA, emitting at 532 nm [124].
A novel on–off CRET system based on phenoxy-dioxetane 7-hydroxycoumarin scaffold for light emission, upon slow chemiexcitation in aqueous solution, was recently reported. The energy donor is covalently linked to a quencher via a peptide linker that is recognizable by metalloproteinases. In the absence of enzymatic activity CRET is on, thus the energy is transferred to the quencher. When the peptide linker is cleaved by enzymes CRET is off, thus light emission is observed (Figure 20). The system was tested in cancer cells, showing good detection levels in matrix metalloproteinase activity [125].

5. The Dual Role of Singlet Oxygen in Chemiluminescence

Singlet oxygen was discovered and confirmed spectroscopically in the early 1960s when the H2O2/hypochlorite system was at the epicenter of the CL studies [131,132,133,134,135,136,137,138]. Its emission at 1270 nm was attributed to the monomeric singlet oxygen and the emissions at 633 nm and 703 nm, to its dimeric aggregate form (Scheme 16). It is noteworthy that the energy difference between the ground state of O2 (3Σg) and its singlet excited state (1Δg, singlet oxygen, 1O2) is 22.5 kcal/mol. Moreover, its lifetime depends significantly on the solvent (e.g., ~59 ms in carbon tetrachloride, 9.8 ± 0.6 μs in methanol-h4, 77 ± 4 μs acetonitrile and 3.7 ± 0.4 μs in water) [139,140].
During recent decades, an increasing number of studies have focused on exploring the role of 1O2 in chemistry, biology, medicine and environmental and material sciences. Lately, the increasing interest of the scientific community in novel therapies has led to further exploration of 1O2 against persisting diseases (i.e., cancer). Thus, a significant amount of the new studies are now focused on the generation modes and the photophysical properties [141], dictating its interaction with other biomolecules in live cells. On the other hand, 1O2 is a very important oxidizing agent in organic chemistry transformations. There are two main approaches for generating 1O2. The first, and more famous one, involves light and a photosensitizer, while the less famous one is hydroperoxide-based and it is often called the “in dark” process, since 1O2 is produced in the absence of light. To avoid confusion between the CL-induced 1O2production and the CL of the 1O2 itself, we should distinguish here the two completely different CL. The energy transfer and radiative processes of the CL energy acceptors or chemiexcited intermediates are illustrated in Figure 21.
The majority of the recent photochemical or CL studies on 1O2 applications employ well-known and established methodologies for generating an efficient amount of the oxidizing agent based on photosensitizers such as TTP, Rose Bengal, Cu2+ [142], Ru2+ and Ir3+ complexes, phthalocyanines [143,144] and other analogues. Kellett and his coworkers have presented a class of di-copper (II) complexes based on the synthetic chemical nuclease [Cu(Phen)2]+ (where Phen = 1,10-phenathroline), that were selective against solid epithelial cancer cells from line panel NCI-60. Among other ROS, their agents are found to catalyze intracellular 1O2 contributing to oxidative DNA damage [145]. Recently, our team has also explored the role of Cu+ complexes in the photochemical production of 1O2. We found and presented for the first time that [Cu(Xantphos)(neoc)]BF4 can be used as an alternative and very efficient photosensitizer in 1O2-mediated C–H allylic oxygenations [146].
Recently, in our group, the plausible production of 1O2 was studied under different CL reaction conditions and in the presence of various sensitizers. In this study, except for the common solvents used in CL procedures, diethylphthalates, the greener ethyl acetate was found to give unexpectedly good results. In addition, several photosensitizers, i.e., Rose Bengal (RB), Methylene Blue, 9,10-diphenylanthracene (9,10-DPA), Eosin Y and Rhodamine B, were tested for light emission through the CL process, with RB providing the best results based on the light emission duration. In the presence of TCPO, H2O2, RB, sodium salicylate and a mixture of ethyl acetate/acetonitrile in a ratio of 2/1, light emission was observed for 40–50 min (Scheme 17). Under these CL conditions and in the presence of 1-phenylcycloalkene, no allylic oxidation product was observed. For comparison, the same solution was bubbled with molecular oxygen and irradiated using a Xenon lamp (300 W, λ > 320 nm) [147,148,149], however, no oxidation products were observed. In the absence of TCPO and H2O2, the corresponding alkene was oxidized leading to the corresponding allylic hydroperoxides via a 1O2 oxidation pathway, within 20 minutes (Scheme 17). These results indicate that the observed CL phenomenon didn’t induce 1O2 production, or the energy transfer and radiative processes of the CL energy acceptors or chemiexcited intermediates are not enough for the oxidation of cycloalkene. Further experiments using different photosensitizers and initial alkenes are in progress to determine this new intermolecular oxidation pathway [150].

6. Future Prospects

Various technologies have emerged during the past few years aiming to fine-tune the molecular scaffolds and the experimental conditions under which CL can be used for the development of more advanced molecular sensors and new materials, in drug delivery, theranostics and polymerization reactions. To that end, several scaffolds such as dioxetanes and luminol-based systems, etc., have already shown great potential and are expected to play a significant role in the years to come. The growing demand for highly efficient PDT platforms that could produce significant amounts of reactive species under CL conditions may also reveal another important research direction that is still unexplored, regarding the replacement of light sources by CL in standard photochemical reactions.
A summary of the major obstacles that cause delay in the expansion of the CL applications include, but are not limited to, (i) the photophysical properties of the CL probe such as the fluorescence quantum yield, emission wavelength, photon flux, CL kinetic profile; (ii) the solubility and stability of the CL probe in the reaction media; (iii) the distance between the energy donor and energy acceptor, plus their emission and absorption spectral overlapping, in the case of direct CL; (iv) the selectivity of the triggering agent and oxidation mechanism of the CL substrates; (v) the efficiency of the emission mechanism (i.e., CIEEL); (vi) the toxicity, when considering bioapplications.
Recently there has been a tremendous increase in the number of new photochemical reactions reported in the literature. Nonetheless, reports of industrial applications utilizing this new knowledge are still scarce and mainly limited to flow-chemistry processes. Maybe nature can inspire the research community to find a solution to this problem through CL?

Author Contributions

M.A.Tz., D.K.G. and M.G.K. collected the literature. M.A.Tz. conducted the experiments with the TCPO and the various photosensitizers, and acquired and analyzed the data. N.V.P. and N.P.K. assisted in the gas chromatographic analysis and data acquisition. M.A.Tz., D.K.G., P.A.A., I.N.L. and M.A.T. wrote the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Hellenic Foundation for Research and Innovation (HFRI) and the General Secretariat for Research and Innovation (GSRI), grant number [776].

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors kindly acknowledge financial support from the Hellenic Foundation for Research and Innovation (HFRI) and the General Secretariat for Research and Innovation (GSRI) under grant agreement No. [776] “PhotoDaLu” (KA97507).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Vacher, M.; Fdez Galván, I.; Ding, B.-W.; Schramm, S.; Berraud-Pache, R.; Naumov, P.; Ferré, N.; Liu, Y.-J.; Navizet, I.; Roca-Sanjuán, D.; et al. Chemi- and Bioluminescence of Cyclic Peroxides. Chem. Rev. 2018, 118, 6927–6974. [Google Scholar] [CrossRef]
  2. McCapra, F. Chemiluminescence and Bioluminescence. J. Photochem. Photobiol. A Chem. 1990, 51, 21–28. [Google Scholar] [CrossRef]
  3. Viviani, V.R. The Origin, Diversity, and Structure Function Relationships of Insect Luciferases. CMLS Cell. Mol. Life Sci. 2002, 59, 1833–1850. [Google Scholar] [CrossRef]
  4. White, E.H.; McCapra, F.; Field, G.F.; McElroy, W.D. The structure and synthesis of firefly luciferin. J. Am. Chem. Soc. 1961, 83, 2402–2403. [Google Scholar] [CrossRef]
  5. Yagur-Kroll, S.; Bilic, B.; Belkin, S. Strategies for Enhancing Bioluminescent Bacterial Sensor Performance by Promoter Region Manipulation: Enhancing Bacterial Sensor Performance. Microb. Biotechnol. 2010, 3, 300–310. [Google Scholar] [CrossRef] [Green Version]
  6. Goto, T.; Takagi, T. Chemiluminescence of a Cypridina Luciferin Analogue, 2-Methyl-6-Phenyl-3,7-Dihydroimidazo[1,2- a ]Pyrazin-3-One, in the Presence of the Xanthine–Xanthine Oxidase System. BCSJ 1980, 53, 833–834. [Google Scholar] [CrossRef] [Green Version]
  7. Toya, Y.; Kayano, T.; Sato, K.; Goto, T. Synthesis and Chemiluminescence Properties of 6-(4-Methoxyphenyl)-2-Methylimidazo[1,2-a]Pyrazin-3(7H)-One and 2-Methyl-6-(2-Naphthyl)Imidazo[1,2-a]Pyrazin-3(7H)-One. BCSJ 1992, 65, 2475–2479. [Google Scholar] [CrossRef]
  8. Teranishi, K. Development of Imidazopyrazinone Red-Chemiluminescent Probes for Detecting Superoxide Anions via a Chemiluminescence Resonance Energy Transfer Method. Luminescence 2007, 22, 147–156. [Google Scholar] [CrossRef]
  9. Sekiya, M.; Umezawa, K.; Sato, A.; Citterio, D.; Suzuki, K. A Novel Luciferin-Based Bright Chemiluminescent Probe for the Detection of Reactive Oxygen Species. Chem. Commun. 2009, 3047–3049. [Google Scholar] [CrossRef] [PubMed]
  10. Marques, S.M.; Esteves da Silva, J.C.G. Firefly Bioluminescence: A Mechanistic Approach of Luciferase Catalyzed Reactions. IUBMB Life 2009, 61, 6–17. [Google Scholar] [CrossRef] [PubMed]
  11. Kim, J.E.; Kalimuthu, S.; Ahn, B.-C. In Vivo Cell Tracking with Bioluminescence Imaging. Nucl. Med. Mol. Imaging 2015, 49, 3–10. [Google Scholar] [CrossRef] [Green Version]
  12. Brown, J.E.; De Weer, P.; Salzberg, B.M. Optical Measurement of Changes in Intracellular Calcium. Biophys. J. 2020, 118, 788–789. [Google Scholar] [CrossRef] [PubMed]
  13. Adam, W.; Kazakov, D.V.; Kazakov, V.P. Singlet-Oxygen Chemiluminescence in Peroxide Reactions. Chem. Rev. 2005, 105, 3371–3387. [Google Scholar] [CrossRef]
  14. Gnaim, S.; Shabat, D. Activity-Based Optical Sensing Enabled by Self-Immolative Scaffolds: Monitoring of Release Events by Fluorescence or Chemiluminescence Output. Acc. Chem. Res. 2019, 52, 2806–2817. [Google Scholar] [CrossRef] [PubMed]
  15. Haris, U.; Kagalwala, H.N.; Kim, Y.L.; Lippert, A.R. Seeking Illumination: The Path to Chemiluminescent 1,2-Dioxetanes for Quantitative Measurements and In Vivo Imaging. Acc. Chem. Res. 2021, 54, 2844–2857. [Google Scholar] [CrossRef] [PubMed]
  16. Chatgilialoglu, C.; Ferreri, C.; Krokidis, M.G.; Masi, A.; Terzidis, M.A. On the Relevance of Hydroxyl Radical to Purine DNA Damage. Free. Radic. Res. 2021, 55, 384–404. [Google Scholar] [CrossRef]
  17. Chatgilialoglu, C.; Krokidis, M.G.; Masi, A.; Barata-Vallejo, S.; Ferreri, C.; Terzidis, M.A.; Szreder, T.; Bobrowski, K. New Insights into the Reaction Paths of Hydroxyl Radicals with Purine Moieties in DNA and Double-Stranded Oligodeoxynucleotides. Molecules 2019, 24, 3860. [Google Scholar] [CrossRef] [Green Version]
  18. Chatgilialoglu, C.; Ferreri, C.; Terzidis, M.A. Purine 5′,8-Cyclonucleoside Lesions: Chemistry and Biology. Chem. Soc. Rev. 2011, 40, 1368. [Google Scholar] [CrossRef]
  19. Terzidis, M.A.; Chatgilialoglu, C. An Ameliorative Protocol for the Quantification of Purine 5′,8-Cyclo-2′-Deoxynucleosides in Oxidized DNA. Front. Chem. 2015, 3, 47. [Google Scholar] [CrossRef] [Green Version]
  20. McCaughan, J.S. Photodynamic Therapy: A Review. Drugs Aging 1999, 15, 49–68. [Google Scholar] [CrossRef]
  21. Dolmans, D.E.; Fukumura, D.; Jain, R.K. Photodynamic Therapy for Cancer. Nat. Rev. Cancer 2003, 3, 380–387. [Google Scholar] [CrossRef]
  22. Zhao, X.; Liu, J.; Fan, J.; Chao, H.; Peng, X. Recent Progress in Photosensitizers for Overcoming the Challenges of Photodynamic Therapy: From Molecular Design to Application. Chem. Soc. Rev. 2021, 50, 4185–4219. [Google Scholar] [CrossRef] [PubMed]
  23. Gunaydin, G.; Gedik, M.E.; Ayan, S. Photodynamic Therapy for the Treatment and Diagnosis of Cancer–A Review of the Current Clinical Status. Front. Chem. 2021, 9, 686303. [Google Scholar] [CrossRef] [PubMed]
  24. Yamaguchi, S.; Kishikawa, N.; Ohyama, K.; Ohba, Y.; Kohno, M.; Masuda, T.; Takadate, A.; Nakashima, K.; Kuroda, N. Evaluation of Chemiluminescence Reagents for Selective Detection of Reactive Oxygen Species. Anal. Chim. Acta 2010, 665, 74–78. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Worsfold, P.; Townshend, A.; Poole, C.F. Encyclopedia of Analytical Science, 2nd ed.; Elsevier Academic Press: Amsterdam, The Netherlands; Boston, MA, USA, 2005; ISBN 978-0-12-764100-3. [Google Scholar]
  26. Qi, Y.; Xiu, F.; Weng, Q. A Novel and Convenient Chemiluminescence Sensing of DNA: Nanometer Interface Effect and DNA Action Mechanism. Sens. Actuators B Chem. 2018, 260, 303–310. [Google Scholar] [CrossRef]
  27. Ling, K.; Jiang, H.; Huang, X.; Li, Y.; Lin, J.; Li, F.-R. Direct Chemiluminescence Detection of Circulating MicroRNAs in Serum Samples Using a Single-Strand Specific Nuclease-Distinguishing Nucleic Acid Hybrid System. Chem. Commun. 2018, 54, 1909–1912. [Google Scholar] [CrossRef] [Green Version]
  28. Li, W.; Zhang, Q.; Zhou, H.; Chen, J.; Li, Y.; Zhang, C.; Yu, C. Chemiluminescence Detection of a Protein through the Aptamer-Controlled Catalysis of a Porphyrin Probe. Anal. Chem. 2015, 87, 8336–8341. [Google Scholar] [CrossRef]
  29. Carter, K.P.; Young, A.M.; Palmer, A.E. Fluorescent Sensors for Measuring Metal Ions in Living Systems. Chem. Rev. 2014, 114, 4564–4601. [Google Scholar] [CrossRef]
  30. Roda, A.; Pasini, P.; Musiani, M.; Girotti, S.; Baraldini, M.; Carrea, G.; Suozzi, A. Chemiluminescent Low-Light Imaging of Biospecific Reactions on Macro- and Microsamples Using a Videocamera-Based Luminograph. Anal. Chem. 1996, 68, 1073–1080. [Google Scholar] [CrossRef]
  31. Roda, A.; Pasini, P.; Musiani, M.; Baraldini, M. Chemiluminescence Imaging Systems for the Analysis of Macrosamples: Microtiter Format, Blot Membrane, and Whole Organs. In Methods in Enzymology; Elsevier: Amsterdam, The Netherlands, 2000; Volume 305, pp. 120–132. ISBN 978-0-12-182206-4. [Google Scholar]
  32. Padoan, A.; Cosma, C.; Sciacovelli, L.; Faggian, D.; Plebani, M. Analytical Performances of a Chemiluminescence Immunoassay for SARS-CoV-2 IgM/IgG and Antibody Kinetics. Clin. Chem. Lab. Med. (CCLM) 2020, 58, 1081–1088. [Google Scholar] [CrossRef] [Green Version]
  33. Yan, Y.; Wang, X.; Hai, X.; Song, W.; Ding, C.; Cao, J.; Bi, S. Chemiluminescence Resonance Energy Transfer: From Mechanisms to Analytical Applications. TrAC Trends Anal. Chem. 2020, 123, 115755. [Google Scholar] [CrossRef]
  34. Yan, Y.; Shi, P.; Song, W.; Bi, S. Chemiluminescence and Bioluminescence Imaging for Biosensing and Therapy: In Vitro and In Vivo Perspectives. Theranostics 2019, 9, 4047–4065. [Google Scholar] [CrossRef]
  35. Delafresnaye, L.; Bloesser, F.R.; Kockler, K.B.; Schmitt, C.W.; Irshadeen, I.M.; Barner-Kowollik, C. All Eyes on Visible-Light Peroxyoxalate Chemiluminescence Read-Out Systems. Chem. Eur. J. 2020, 26, 114–127. [Google Scholar] [CrossRef] [Green Version]
  36. Hananya, N.; Shabat, D. Recent Advances and Challenges in Luminescent Imaging: Bright Outlook for Chemiluminescence of Dioxetanes in Water. ACS Cent. Sci. 2019, 5, 949–959. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Albini, A. Photochemistry: Past, Present and Future; Springer: Berlin, Germany, 2015; ISBN 3-662-47977-X. [Google Scholar]
  38. Crespi, S.; Protti, S. (Eds.) Photochemistry: Volume 49; Photochemistry; Royal Society of Chemistry: Cambridge, UK, 2021; Volume 49, ISBN 978-1-83916-388-3. [Google Scholar]
  39. Powe, A.M.; Fletcher, K.A.; St. Luce, N.N.; Lowry, M.; Neal, S.; McCarroll, M.E.; Oldham, P.B.; McGown, L.B.; Warner, I.M. Molecular Fluorescence, Phosphorescence, and Chemiluminescence Spectrometry. Anal. Chem. 2004, 76, 4614–4634. [Google Scholar] [CrossRef]
  40. Shimomura, O. Bioluminescence: Chemical Principles and Methods; World Scientific: Singapore, 2006; ISBN 978-981-256-801-4. [Google Scholar]
  41. Magalhães, C.M.; Esteves da Silva, J.C.G.; Pinto da Silva, L. Chemiluminescence and Bioluminescence as an Excitation Source in the Photodynamic Therapy of Cancer: A Critical Review. ChemPhysChem 2016, 17, 2286–2294. [Google Scholar] [CrossRef] [PubMed]
  42. Miao, W. Electrogenerated Chemiluminescence and Its Biorelated Applications. Chem. Rev. 2008, 108, 2506–2553. [Google Scholar] [CrossRef]
  43. Albrecht, H.O. Über Die Chemiluminescenz Des Aminophthalsäurehydrazids. Z. Phys. Chem. 1928, 136, 321–330. [Google Scholar] [CrossRef]
  44. Vaughan, W.R. The Chemistry of the Phthalazines. Chem. Rev. 1948, 43, 447–508. [Google Scholar] [CrossRef]
  45. White, E.H.; Zafiriou, O.; Kagi, H.H.; Hill, J.H. Chemilunimescence of Luminol: The Chemcial Reaction. J. Am. Chem. Soc. 1964, 86, 940–941. [Google Scholar] [CrossRef]
  46. Yu, Y.; Mallick, S.; Wang, M.; Börjesson, K. Barrier-Free Reverse-Intersystem Crossing in Organic Molecules by Strong Light-Matter Coupling. Nat Commun. 2021, 12, 3255. [Google Scholar] [CrossRef]
  47. Wada, Y.; Nakagawa, H.; Matsumoto, S.; Wakisaka, Y.; Kaji, H. Organic Light Emitters Exhibiting Very Fast Reverse Intersystem Crossing. Nat. Photonics 2020, 14, 643–649. [Google Scholar] [CrossRef]
  48. Cui, L.-S.; Gillett, A.J.; Zhang, S.-F.; Ye, H.; Liu, Y.; Chen, X.-K.; Lin, Z.-S.; Evans, E.W.; Myers, W.K.; Ronson, T.K.; et al. Fast Spin-Flip Enables Efficient and Stable Organic Electroluminescence from Charge-Transfer States. Nat. Photonics 2020, 14, 636–642. [Google Scholar] [CrossRef]
  49. Nakamura, M.; Nakamura, S. One- and Two-Electron Oxidations of Luminol by Peroxidase Systems. Free. Radic. Biol. Med. 1998, 24, 537–544. [Google Scholar] [CrossRef]
  50. Morin, J.G. Based on a Review of the Data, Use of the Term ‘Cypridinid’ Solves the Cypridina/Vargula Dilemma for Naming the Constituents of the Luminescent System of Ostracods in the Family Cypridinidae. Luminescence 2011, 26, 1–4. [Google Scholar] [CrossRef]
  51. Johnson, F.H.; Shimomura, O. Introduction to the Cypridina System. Methods Enzymol. 1978, 57, 331–364. [Google Scholar] [CrossRef]
  52. Khakhar, A.; Starker, C.G.; Chamness, J.C.; Lee, N.; Stokke, S.; Wang, C.; Swanson, R.; Rizvi, F.; Imaizumi, T.; Voytas, D.F. Building customizable auto-luminescent luciferase-based reporters in plants. Elife 2020, 9, e52786. [Google Scholar] [CrossRef]
  53. Zheng, Z.; Wang, L.; Tang, W.; Chen, P.; Zhu, H.; Yuan, Y.; Li, G.; Zhang, H.; Liang, G. Hydrazide D-Luciferin for in Vitro Selective Detection and Intratumoral Imaging of Cu2+. Biosens. Bioelectron. 2016, 83, 200–204. [Google Scholar] [CrossRef] [PubMed]
  54. Yang, M.; Huang, J.; Fan, J.; Du, J.; Pu, K.; Peng, X. Chemiluminescence for Bioimaging and Therapeutics: Recent Advances and Challenges. Chem. Soc. Rev. 2020, 49, 6800–6815. [Google Scholar] [CrossRef]
  55. Li, Z.; Chen, X.; Teng, X.; Lu, C. Chemiluminescence as a New Indicator for Monitoring Hydroxylated Intermediates in Persulfate-Based Advanced Oxidation Processes. J. Phys. Chem. C 2019, 123, 21704–21712. [Google Scholar] [CrossRef]
  56. Vakh, C.; Kuzmin, A.; Sadetskaya, A.; Bogdanova, P.; Voznesenskiy, M.; Osmolovskaya, O.; Bulatov, A. Cobalt-Doped Hydroxyapatite Nanoparticles as a New Eco-Friendly Catalyst of Luminol–H2O2 Based Chemiluminescence Reaction: Study of Key Factors, Improvement the Activity and Analytical Application. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2020, 237, 118382. [Google Scholar] [CrossRef]
  57. Zambrano, G.; Nastri, F.; Pavone, V.; Lombardi, A.; Chino, M. Use of an Artificial Miniaturized Enzyme in Hydrogen Peroxide Detection by Chemiluminescence. Sensors 2020, 20, 3793. [Google Scholar] [CrossRef] [PubMed]
  58. Yang, C.P.; He, L.; Huang, C.Z.; Li, Y.F.; Zhen, S.J. Continuous Singlet Oxygen Generation for Persistent Chemiluminescence in Cu-MOFs-Based Catalytic System. Talanta 2021, 221, 121498. [Google Scholar] [CrossRef]
  59. Nishinaka, Y.; Aramaki, Y.; Yoshida, H.; Masuya, H.; Sugawara, T.; Ichimori, Y. A New Sensitive Chemiluminescence Probe, L-012, for Measuring the Production of Superoxide Anion by Cells. Biochem. Biophys. Res. Commun. 1993, 193, 554–559. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Yang, J.; Yin, W.; Van, R.; Yin, K.; Wang, P.; Zheng, C.; Zhu, B.; Ran, K.; Zhang, C.; Kumar, M.; et al. Turn-on Chemiluminescence Probes and Dual-Amplification of Signal for Detection of Amyloid Beta Species in Vivo. Nat Commun. 2020, 11, 4052. [Google Scholar] [CrossRef] [PubMed]
  61. Green, O.; Gnaim, S.; Blau, R.; Eldar-Boock, A.; Satchi-Fainaro, R.; Shabat, D. Near-Infrared Dioxetane Luminophores with Direct Chemiluminescence Emission Mode. J. Am. Chem. Soc. 2017, 139, 13243–13248. [Google Scholar] [CrossRef] [PubMed]
  62. Gnaim, S.; Scomparin, A.; Das, S.; Blau, R.; Satchi-Fainaro, R.; Shabat, D. Direct Real-Time Monitoring of Prodrug Activation by Chemiluminescence. Angew. Chem. Int. Ed. 2018, 57, 9033–9037. [Google Scholar] [CrossRef]
  63. Das, S.; Ihssen, J.; Wick, L.; Spitz, U.; Shabat, D. Chemiluminescent Carbapenem-Based Molecular Probe for Detection of Carbapenemase Activity in Live Bacteria. Chem. Eur. J. 2020, 26, 3647–3652. [Google Scholar] [CrossRef]
  64. Gutkin, S.; Green, O.; Raviv, G.; Shabat, D.; Portnoy, O. Powerful Chemiluminescence Probe for Rapid Detection of Prostate Specific Antigen Proteolytic Activity: Forensic Identification of Human Semen. Bioconjug. Chem. 2020, 31, 2488–2493. [Google Scholar] [CrossRef]
  65. Yue, L.; Liu, Y.-T. Mechanistic Insight into PH-Dependent Luminol Chemiluminescence in Aqueous Solution. J. Phys. Chem. B 2020, 124, 7682–7693. [Google Scholar] [CrossRef] [PubMed]
  66. Kamidate, T.; Katayama, A.; Ichihashi, H.; Watanabe, H. Characterization of Peroxidases in Luminol Chemiluminescence Coupled with Copper-Catalysed Oxidation of Cysteamine. J. Biolumin. Chemilumin. 1994, 9, 279–286. [Google Scholar] [CrossRef]
  67. Gorsuch, J.D.; Hercules, D.M. Studies on the chemiluminescence of luminol in dimethylsulfoxide and dimethylsulfoxide-water mixtures. Photochem. Photobiol. 1972, 15, 567–583. [Google Scholar] [CrossRef]
  68. Lee, J.; Seliger, H.H. Quantum yields of the luminol chemiluminescence reaction in aqueous and aprotic solvents. Photochem. Photobiol. 1972, 15, 227–237. [Google Scholar] [CrossRef]
  69. Cormier, M.J.; Prichard, P.M. An Investigation of the Mechanism of the Luminescent Peroxidation of Luminol by Stopped Flow Techniques. J. Biol. Chem. 1968, 243, 4706–4714. [Google Scholar] [CrossRef]
  70. Li, L.; Arnold, M.A.; Dordick, J.S. Mathematical Model for the Luminol Chemiluminescence Reaction Catalyzed by Peroxidase: Peroxidase-catalyzed luminol chemiluminescence. Biotechnol. Bioeng. 1993, 41, 1112–1120. [Google Scholar] [CrossRef] [PubMed]
  71. Cercek, B.; Cercek, B.; Roby, K.; Cercek, L. Effect of Oxygen Abstraction on the Peroxidase-Luminol-Perborate System: Relevance to the HRP Enhanced Chemiluminescence Mechanism. J. Biolumin. Chemilumin. 1994, 9, 273–277. [Google Scholar] [CrossRef]
  72. Mikroulis, T.; Cuquerella, M.C.; Giussani, A.; Pantelia, A.; Rodríguez-Muñiz, G.M.; Rotas, G.; Roca-Sanjuán, D.; Miranda, M.A.; Vougioukalakis, G.C. Building a Functionalizable, Potent Chemiluminescent Agent: A Rational Design Study on 6,8-Substituted Luminol Derivatives. J. Org. Chem. 2021, 86, 11388–11398. [Google Scholar] [CrossRef]
  73. Brundrett, R.B.; White, E.H. Synthesis and Chemiluminescence of Derivatives of Luminol and Isoluminol. J. Am. Chem. Soc. 1974, 96, 7497–7502. [Google Scholar] [CrossRef]
  74. Karatani, H. Microenvironmental Effects of Water-Soluble Polymers on the Chemiluminescence of Luminol and Its Analogs. BCSJ 1987, 60, 2023–2029. [Google Scholar] [CrossRef]
  75. Baader, W.J.; Stevani, C.V.; Bastos, E.L. Chemiluminescence of Organic Peroxides The Authors Dedicate This Chapter to the Late Prof. Dr. Giuseppe Cilento (Universidade de São Paulo), Whose Untimely Demise in 1994 Saddened Everyone Who Knew Him as an Excellent Scientist and Outstanding Human Being. This Chapter Is Also Dedicated to Prof. Waldemar Adam (Universität Würzburg, Now ‘Retired’ in Puerto Rico), Who Was Directly or Indirectly Responsible for the Research Interests of the Authors. In PATAI’S Chemistry of Functional Groups; Rappoport, Z., Ed.; John Wiley & Sons, Ltd.: Chichester, UK, 2009; ISBN 978-0-470-68253-1. [Google Scholar]
  76. Tonkin, S.A.; Bos, R.; Dyson, G.A.; Lim, K.F.; Russell, R.A.; Watson, S.P.; Hindson, C.M.; Barnett, N.W. Studies on the Mechanism of the Peroxyoxalate Chemiluminescence Reaction. Anal. Chim. Acta 2008, 614, 173–181. [Google Scholar] [CrossRef]
  77. Farahani, P.; Baader, W.J. Unimolecular Decomposition Mechanism of 1,2-Dioxetanedione: Concerted or Biradical? That Is the Question! J. Phys. Chem. A 2017, 121, 1189–1194. [Google Scholar] [CrossRef] [PubMed]
  78. Bos, R.; Tonkin, S.A.; Hanson, G.R.; Hindson, C.M.; Lim, K.F.; Barnett, N.W. In Search of a Chemiluminescence 1,4-Dioxy Biradical. J. Am. Chem. Soc. 2009, 131, 2770–2771. [Google Scholar] [CrossRef]
  79. Orosz, G. The Role of Diaryl Oxalates in Peroxioxalate Chemiluminescence. Tetrahedron 1989, 45, 3493–3506. [Google Scholar] [CrossRef]
  80. Stevani, C.V.; Lima, D.F.; Toscano, V.G.; Baader, W.J. Kinetic Studies on the Peroxyoxalate Chemiluminescent Reaction: Imidazole as a Nucleophilic Catalyst. J. Chem. Soc. Perkin Trans. 2 1996, 989–995. [Google Scholar] [CrossRef]
  81. Silva, S.M.; Casallanovo, F.; Oyamaguchi, K.H.; Ciscato, L.F.; Stevani, C.V.; Baader, W.J. Kinetic Studies on the Peroxyoxalate Chemiluminescence Reaction: Determination of the Cyclization Rate Constant. Luminescence 2002, 17, 313–320. [Google Scholar] [CrossRef] [PubMed]
  82. Souza, G.A.; Lang, A.P.; Baader, W.J. Mechanistic Studies on the Peroxyoxalate Chemiluminescence Using Sodium Salicylate as Base Catalyst. Photochem. Photobiol. 2017, 93, 1423–1429. [Google Scholar] [CrossRef] [PubMed]
  83. Jonsson, T.; Irgum, K. New Nucleophilic Catalysts for Bright and Fast Peroxyoxalate Chemiluminescence. Anal. Chem. 2000, 72, 1373–1380. [Google Scholar] [CrossRef] [PubMed]
  84. Cabello, M.C.; Souza, G.A.; Bello, L.V.; Baader, W.J. Mechanistic Studies on the Salicylate-Catalyzed Peroxyoxalate Chemiluminescence in Aqueous Medium. Photochem. Photobiol. 2020, 96, 28–36. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Augusto, F.A.; Bartoloni, F.H.; Cabello, M.C.; dos Santos, A.P.F.; Baader, W.J. Kinetic Studies on 2,6-Lutidine Catalyzed Peroxyoxalate Chemiluminescence in Organic and Aqueous Medium: Evidence for General Base Catalysis. J. Photochem. Photobiol. A Chem. 2019, 382, 111967. [Google Scholar] [CrossRef]
  86. Shah, S.N.A.; Shah, A.H.; Dou, X.; Khan, M.; Lin, L.; Lin, J.-M. Radical-Triggered Chemiluminescence of Phenanthroline Derivatives: An Insight into Radical–Aromatic Interaction. ACS Omega 2019, 4, 15004–15011. [Google Scholar] [CrossRef] [Green Version]
  87. Shah, S.N.A.; Khan, M.; Rehman, Z.U. A Prolegomena of Periodate and Peroxide Chemiluminescence. TrAC Trends Anal. Chem. 2020, 122, 115722. [Google Scholar] [CrossRef]
  88. Watanabe, N.; Takatsuka, H.; Ijuin, H.K.; Matsumoto, M. Highly Effective and Rapid Emission of Light from Bicyclic Dioxetanes Bearing a 3-Hydroxyphenyl Substituted with a 4-p-Oligophenylene Moiety in an Aqueous System: Two Different Ways for the Enhancement of Chemiluminescence Efficiency. Tetrahedron 2020, 76, 131203. [Google Scholar] [CrossRef]
  89. Schaap, A.P.; Chen, T.-S.; Handley, R.S.; DeSilva, R.; Giri, B.P. Chemical and Enzymatic Triggering of 1,2-Dioxetanes. 2: Fluoride-Induced Chemiluminescence from Tert-Butyldimethylsilyloxy-Substituted Dioxetanes. Tetrahedron Lett. 1987, 28, 1155–1158. [Google Scholar] [CrossRef]
  90. Schaap, A.P.; Handley, R.S.; Giri, B.P. Chemical and Enzymatic Triggering of 1,2-Dioxetanes. 1: Aryl Esterase-Catalyzed Chemiluminescence from a Naphthyl Acetate-Substituted Dioxetane. Tetrahedron Lett. 1987, 28, 935–938. [Google Scholar] [CrossRef]
  91. Schaap, A.P.; Sandison, M.D.; Handley, R.S. Chemical and Enzymatic Triggering of 1,2-Dioxetanes. 3: Alkaline Phosphatase-Catalyzed Chemiluminescence from an Aryl Phosphate-Substituted Dioxetane. Tetrahedron Lett. 1987, 28, 1159–1162. [Google Scholar] [CrossRef]
  92. Augusto, F.A.; de Souza, G.A.; de Souza Júnior, S.P.; Khalid, M.; Baader, W.J. Efficiency of Electron Transfer Initiated Chemiluminescence. Photochem. Photobiol. 2013, 89, 1299–1317. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Adam, W.; Bronstein, I.; Trofimov, A.V.; Vasil’ev, R.F. Solvent-Cage Effect (Viscosity Dependence) as a Diagnostic Probe for the Mechanism of the Intramolecular Chemically Initiated Electron-Exchange Luminescence (CIEEL) Triggered from a Spiroadamantyl-Substituted Dioxetane. J. Am. Chem. Soc. 1999, 121, 958–961. [Google Scholar] [CrossRef]
  94. Ryan, L.S.; Nakatsuka, A.; Lippert, A.R. PhotoactivaTable 1,2-Dioxetane Chemiluminophores. Results Chem. 2021, 3, 100106. [Google Scholar] [CrossRef]
  95. Zadykowicz, B.; Czechowska, J.; Ożóg, A.; Renkevich, A.; Krzymiński, K. Effective Chemiluminogenic Systems Based on Acridinium Esters Bearing Substituents of Various Electronic and Steric Properties. Org. Biomol. Chem. 2016, 14, 652–668. [Google Scholar] [CrossRef]
  96. Czechowska, J.; Kawecka, A.; Romanowska, A.; Marczak, M.; Wityk, P.; Krzymiński, K.; Zadykowicz, B. Chemiluminogenic Acridinium Salts: A Comparison Study. Detection of Intermediate Entities Appearing upon Light Generation. J. Lumin. 2017, 187, 102–112. [Google Scholar] [CrossRef]
  97. Nakazono, M.; Nanbu, S.; Akita, T.; Hamase, K. Synthesis, Chemiluminescence, and Application of 2,4-Disubstituted Phenyl 10-Methyl-10λ4-Acridine-9-Carboxylates. Dyes Pigments 2019, 170, 107628. [Google Scholar] [CrossRef]
  98. Ren, L.; Cui, H. Chemiluminescence Accompanied by the Reaction of Acridinium Ester and Manganese (II): Reaction of Acridinium Ester and Manganese(II). Luminescence 2014, 29, 929–932. [Google Scholar] [CrossRef]
  99. Natrajan, A.; Wen, D. Effect of Branching in Remote Substituents on Light Emission and Stability of Chemiluminescent Acridinium Esters. RSC Adv. 2014, 4, 21852–21863. [Google Scholar] [CrossRef]
  100. Krzymiński, K.; Ożóg, A.; Malecha, P.; Roshal, A.D.; Wróblewska, A.; Zadykowicz, B.; Błażejowski, J. Chemiluminogenic Features of 10-Methyl-9-(Phenoxycarbonyl)Acridinium Trifluoromethanesulfonates Alkyl Substituted at the Benzene Ring in Aqueous Media. J. Org. Chem. 2011, 76, 1072–1085. [Google Scholar] [CrossRef]
  101. McCapra, F. The Chemiluminescence of Organic Compounds. Q. Rev. Chem. Soc. 1966, 20, 485. [Google Scholar] [CrossRef]
  102. Weeks, I.; Beheshti, I.; McCapra, F.; Campbell, A.K.; Woodhead, J.S. Acridinium Esters as High-Specific-Activity Labels in Immunoassay. Clin. Chem. 1983, 29, 1474–1479. [Google Scholar] [CrossRef] [PubMed]
  103. Natrajan, A.; Sharpe, D. Synthesis and Properties of Differently Charged Chemiluminescent Acridinium Ester Labels. Org. Biomol. Chem. 2013, 11, 1026. [Google Scholar] [CrossRef]
  104. Pieńkos, M.; Zadykowicz, B. Computational Insights on the Mechanism of the Chemiluminescence Reaction of New Group of Chemiluminogens—10-Methyl-9-Thiophenoxycarbonylacridinium Cations. IJMS 2020, 21, 4417. [Google Scholar] [CrossRef]
  105. Nakazono, M.; Nanbu, S.; Akita, T.; Hamase, K. Chemiluminescence of Methoxycarbonylphenyl 10-Methyl-10λ4 -2,7-Disubstituted Acridine-9-Carboxylate Derivatives. J. Photochem. Photobiol. A Chem. 2020, 403, 112851. [Google Scholar] [CrossRef]
  106. Huang, X.; Li, L.; Qian, H.; Dong, C.; Ren, J. A Resonance Energy Transfer between Chemiluminescent Donors and Luminescent Quantum-Dots as Acceptors (CRET). Angew. Chem. Int. Ed. 2006, 45, 5140–5143. [Google Scholar] [CrossRef]
  107. Tanielian, C.; Mechin, R.; Seghrouchni, R.; Schweitzer, C. Mechanistic and Kinetic Aspects of Photosensitization in the Presence of Oxygen†§. Photochem. Photobiol. 2000, 71, 12. [Google Scholar] [CrossRef]
  108. Greer, A. Christopher Foote’s Discovery of the Role of Singlet Oxygen [1O2 (1Δg)] in Photosensitized Oxidation Reactions. Acc. Chem. Res. 2006, 39, 797–804. [Google Scholar] [CrossRef]
  109. Stratakis, M.; Orfanopoulos, M. Regioselectivity in the Ene Reaction of Singlet Oxygen with Alkenes Bearing an Electron Withdrawing Group at β- Position. Tetrahedron Lett. 1997, 38, 1067–1070. [Google Scholar] [CrossRef]
  110. You, Y. Chemical Tools for the Generation and Detection of Singlet Oxygen. Org. Biomol. Chem. 2018, 16, 4044–4060. [Google Scholar] [CrossRef]
  111. Tanielian, C. Decatungstate Photocatalysis. Coord. Chem. Rev. 1998, 178, 1165–1181. [Google Scholar] [CrossRef]
  112. Tzirakis, M.D.; Lykakis, I.N.; Orfanopoulos, M. Decatungstate as an Efficient Photocatalyst in Organic Chemistry. Chem. Soc. Rev. 2009, 38, 2609. [Google Scholar] [CrossRef]
  113. Ravelli, D.; Protti, S.; Fagnoni, M. Decatungstate Anion for Photocatalyzed “Window Ledge” Reactions. Acc. Chem. Res. 2016, 49, 2232–2242. [Google Scholar] [CrossRef]
  114. Meyer, S.; Tietze, D.; Rau, S.; Schäfer, B.; Kreisel, G. Photosensitized Oxidation of Citronellol in Microreactors. J. Photochem. Photobiol. A Chem. 2007, 186, 248–253. [Google Scholar] [CrossRef]
  115. Samia, A.C.S.; Chen, X.; Burda, C. Semiconductor Quantum Dots for Photodynamic Therapy. J. Am. Chem. Soc. 2003, 125, 15736–15737. [Google Scholar] [CrossRef]
  116. An, W.; Mason, R.P.; Lippert, A.R. Energy Transfer Chemiluminescence for Ratiometric PH Imaging. Org. Biomol. Chem. 2018, 16, 4176–4182. [Google Scholar] [CrossRef]
  117. Lee, E.S.; Deepagan, V.G.; You, D.G.; Jeon, J.; Yi, G.-R.; Lee, J.Y.; Lee, D.S.; Suh, Y.D.; Park, J.H. Nanoparticles Based on Quantum Dots and a Luminol Derivative: Implications for in Vivo Imaging of Hydrogen Peroxide by Chemiluminescence Resonance Energy Transfer. Chem. Commun. 2016, 52, 4132–4135. [Google Scholar] [CrossRef] [PubMed]
  118. Teng, Y.; Li, M.; Huang, X.; Ren, J. Singlet Oxygen Generation in Ferriporphyrin-Polymer Dots Catalyzed Chemiluminescence System for Cancer Therapy. ACS Appl. Bio Mater. 2020, 3, 5020–5029. [Google Scholar] [CrossRef]
  119. Wang, C.; Meng, X.; Li, Z.; Li, M.; Jin, M.; Liu, R.; Yagci, Y. Chemiluminescence Induced Cationic Photopolymerization Using Sulfonium Salt. ACS Macro Lett. 2020, 9, 471–475. [Google Scholar] [CrossRef]
  120. Liu, L.; Mason, R.P. Imaging β-Galactosidase Activity in Human Tumor Xenografts and Transgenic Mice Using a Chemiluminescent Substrate. PLoS ONE 2010, 5, e12024. [Google Scholar] [CrossRef]
  121. Cao, J.; Campbell, J.; Liu, L.; Mason, R.P.; Lippert, A.R. In Vivo Chemiluminescent Imaging Agents for Nitroreductase and Tissue Oxygenation. Anal. Chem. 2016, 88, 4995–5002. [Google Scholar] [CrossRef] [Green Version]
  122. Cao, J.; Lopez, R.; Thacker, J.M.; Moon, J.Y.; Jiang, C.; Morris, S.N.S.; Bauer, J.H.; Tao, P.; Mason, R.P.; Lippert, A.R. Chemiluminescent Probes for Imaging H2S in Living Animals. Chem. Sci. 2015, 6, 1979–1985. [Google Scholar] [CrossRef] [Green Version]
  123. Ryan, L.S.; Gerberich, J.; Haris, U.; Nguyen, D.; Mason, R.P.; Lippert, A.R. Ratiometric PH Imaging Using a 1,2-Dioxetane Chemiluminescence Resonance Energy Transfer Sensor in Live Animals. ACS Sens. 2020, 5, 2925–2932. [Google Scholar] [CrossRef]
  124. Suzuki, N.; Suetsuna, K.; Mashiko, S.; Yoda, B.; Nomoto, T.; Toya, Y.; Inaba, H.; Goto, T. Reaction Rates for the Chemiluminescence of Cypridina Luciferin Analogues with Superoxide: A Quenching Experiment with Superoxide Dismutase. Agric. Biol. Chem. 1991, 55, 157–160. [Google Scholar] [CrossRef]
  125. Hananya, N.; Press, O.; Das, A.; Scomparin, A.; Satchi-Fainaro, R.; Sagi, I.; Shabat, D. Persistent Chemiluminescent Glow of Phenoxy-dioxetane Luminophore Enables Unique CRET-Based Detection of Proteases. Chem. Eur. J. 2019, 25, 14679–14687. [Google Scholar] [CrossRef]
  126. Song, Q.; Yan, X.; Cui, H.; Ma, M. Efficient Cascade Resonance Energy Transfer in Dynamic Nanoassembly for Intensive and Long-Lasting Multicolor Chemiluminescence. ACS Nano 2020, 14, 3696–3702. [Google Scholar] [CrossRef]
  127. Zhang, K.; Sun, M.; Song, H.; Su, Y.; Lv, Y. Synergistic Chemiluminescence Nanoprobe: Au Clusters-Cu2+ -Induced Chemiexcitation of Cyclic Peroxides and Resonance Energy Transfer. Chem. Commun. 2020, 56, 3151–3154. [Google Scholar] [CrossRef] [PubMed]
  128. An, H.; Guo, C.; Li, D.; Liu, R.; Xu, X.; Guo, J.; Ding, J.; Li, J.; Chen, W.; Zhang, J. Hydrogen Peroxide-Activatable Nanoparticles for Luminescence Imaging and In Situ Triggerable Photodynamic Therapy of Cancer. ACS Appl. Mater. Interfaces 2020, 12, 17230–17243. [Google Scholar] [CrossRef]
  129. Liu, H.; Sun, M.; Su, Y.; Deng, D.; Hu, J.; Lv, Y. Chemiluminescence of Black Phosphorus Quantum Dots Induced by Hypochlorite and Peroxide. Chem. Commun. 2018, 54, 7987–7990. [Google Scholar] [CrossRef] [PubMed]
  130. Liu, H.; Su, Y.; Sun, T.; Deng, D.; Lv, Y. Engineering the Energy Gap of Black Phosphorene Quantum Dots by Surface Modification for Efficient Chemiluminescence. Chem. Commun. 2020, 56, 1891–1894. [Google Scholar] [CrossRef]
  131. Zhang, D.; Zheng, Y.; Dou, X.; Lin, H.; Shah, S.N.A.; Lin, J.-M. Heterogeneous Chemiluminescence from Gas–Solid Phase Interactions of Ozone with Alcohols, Phenols, and Saccharides. Langmuir 2017, 33, 3666–3671. [Google Scholar] [CrossRef]
  132. Gao, H.-Y.; Mao, L.; Li, F.; Xie, L.-N.; Huang, C.-H.; Shao, J.; Shao, B.; Kalyanaraman, B.; Zhu, B.-Z. Mechanism of Intrinsic Chemiluminescence Production from the Degradation of Persistent Chlorinated Phenols by the Fenton System: A Structure–Activity Relationship Study and the Critical Role of Quinoid and Semiquinone Radical Intermediates. Environ. Sci. Technol. 2017, 51, 2934–2943. [Google Scholar] [CrossRef]
  133. Zou, F.; Zhou, W.; Guan, W.; Lu, C.; Tang, B.Z. Screening of Photosensitizers by Chemiluminescence Monitoring of Formation Dynamics of Singlet Oxygen during Photodynamic Therapy. Anal. Chem. 2016, 88, 9707–9713. [Google Scholar] [CrossRef] [PubMed]
  134. Ghogare, A.A.; Greer, A. Using Singlet Oxygen to Synthesize Natural Products and Drugs. Chem. Rev. 2016, 116, 9994–10034. [Google Scholar] [CrossRef] [PubMed]
  135. Yang, Z.; Cao, Y.; Li, J.; Lu, M.; Jiang, Z.; Hu, X. Smart CuS Nanoparticles as Peroxidase Mimetics for the Design of Novel Label-Free Chemiluminescent Immunoassay. ACS Appl. Mater. Interfaces 2016, 8, 12031–12038. [Google Scholar] [CrossRef]
  136. Shu, J.; Qiu, Z.; Zhou, Q.; Lin, Y.; Lu, M.; Tang, D. Enzymatic Oxydate-Triggered Self-Illuminated Photoelectrochemical Sensing Platform for Portable Immunoassay Using Digital Multimeter. Anal. Chem. 2016, 88, 2958–2966. [Google Scholar] [CrossRef]
  137. Zhang, H.; Zhang, X.; Dong, S. Enhancement of the Carbon Dots/K2S2O8 Chemiluminescence System Induced by Triethylamine. Anal. Chem. 2015, 87, 11167–11170. [Google Scholar] [CrossRef] [Green Version]
  138. Liang, Y.-F.; Wang, X.; Yuan, Y.; Liang, Y.; Li, X.; Jiao, N. Ligand-Promoted Pd-Catalyzed Oxime Ether Directed C–H Hydroxylation of Arenes. ACS Catal. 2015, 5, 6148–6152. [Google Scholar] [CrossRef]
  139. Bregnhøj, M.; Westberg, M.; Jensen, F.; Ogilby, P.R. Solvent-Dependent Singlet Oxygen Lifetimes: Temperature Effects Implicate Tunneling and Charge-Transfer Interactions. Phys. Chem. Chem. Phys. 2016, 18, 22946–22961. [Google Scholar] [CrossRef] [PubMed]
  140. Wilkinson, F.; Helman, W.P.; Ross, A.B. Rate Constants for the Decay and Reactions of the Lowest Electronically Excited Singlet State of Molecular Oxygen in Solution. An Expanded and Revised Compilation. J. Phys. Chem. Ref. Data 1995, 24, 663–677. [Google Scholar] [CrossRef] [Green Version]
  141. Ouyang, H.; Zhang, L.; Jiang, S.; Wang, W.; Zhu, C.; Fu, Z. Co Single-Atom Catalysts Boost Chemiluminescence. Chem. Eur. J. 2020, 26, 7583–7588. [Google Scholar] [CrossRef] [PubMed]
  142. Bhattacharyya, A.; Dixit, A.; Banerjee, S.; Roy, B.; Kumar, A.; Karande, A.A.; Chakravarty, A.R. BODIPY Appended Copper(II) Complexes for Cellular Imaging and Singlet Oxygen Mediated Anticancer Activity in Visible Light. RSC Adv. 2016, 6, 104474–104482. [Google Scholar] [CrossRef]
  143. McRae, E.K.S.; Nevonen, D.E.; McKenna, S.A.; Nemykin, V.N. Binding and Photodynamic Action of the Cationic Zinc Phthalocyanines with Different Types of DNA toward Understanding of Their Cancer Therapy Activity. J. Inorg. Biochem. 2019, 199, 110793. [Google Scholar] [CrossRef]
  144. Binder, S.; Hosikova, B.; Mala, Z.; Zarska, L.; Kolarova, H. Effect of ClAlPcS2 Photodynamic and Sonodynamic Therapy on Hela Cells. Physiol. Res. 2019, 68, S375–S384. [Google Scholar] [CrossRef]
  145. Slator, C.; Molphy, Z.; McKee, V.; Long, C.; Brown, T.; Kellett, A. Di-Copper Metallodrugs Promote NCI-60 Chemotherapy via Singlet Oxygen and Superoxide Production with Tandem TA/TA and AT/AT Oligonucleotide Discrimination. Nucleic Acids Res. 2018, 46, 2733–2750. [Google Scholar] [CrossRef]
  146. Kallitsakis, M.G.; Gioftsidou, D.K.; Tzani, M.A.; Angaridis, P.A.; Terzidis, M.A.; Lykakis, I.N. Selective C–H Allylic Oxygenation of Cycloalkenes and Terpenoids Photosensitized by [Cu(Xantphos)(Neoc)]BF4. J. Org. Chem. 2021, 86, 13503–13513. [Google Scholar] [CrossRef]
  147. Kallitsakis, M.G.; Ioannou, D.I.; Terzidis, M.A.; Kostakis, G.E.; Lykakis, I.N. Selective Photoinduced Reduction of Nitroarenes to N -Arylhydroxylamines. Org. Lett. 2020, 22, 4339–4343. [Google Scholar] [CrossRef] [PubMed]
  148. Symeonidis, T.S.; Athanasoulis, A.; Ishii, R.; Uozumi, Y.; Yamada, Y.M.A.; Lykakis, I.N. Photocatalytic Aerobic Oxidation of Alkenes into Epoxides or Chlorohydrins Promoted by a Polymer-Supported Decatungstate Catalyst. ChemPhotoChem 2017, 1, 479–484. [Google Scholar] [CrossRef]
  149. Symeonidis, T.S.; Tamiolakis, I.; Armatas, G.S.; Lykakis, I.N. Green Photocatalytic Organic Transformations by Polyoxometalates vs. Mesoporous TiO 2 Nanoparticles: Selective Aerobic Oxidation of Alcohols. Photochem. Photobiol. Sci. 2015, 14, 563–568. [Google Scholar] [CrossRef] [PubMed]
  150. Tzani, M.A.; (Department of Chemistry, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece); Terzidis, M.A.; (Department of Nutritional Sciences and Dietetics, International Hellenic University, Sindos Campus, 57400 Thessaloniki, Greece); Lykakis, I.N.; (Department of Chemistry, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece). Unpublished work. 2021.
Molecules 26 07664 g001 550
Figure 1. Direct (a) and indirect (b) chemiluminescence.
Figure 1. Direct (a) and indirect (b) chemiluminescence.
Molecules 26 07664 g001
Molecules 26 07664 g002 550
Figure 2. Jablonski diagram showing typical photoexcitation and radiative relaxation.
Figure 2. Jablonski diagram showing typical photoexcitation and radiative relaxation.
Molecules 26 07664 g002
Molecules 26 07664 g003 550
Figure 3. Electrogenerated chemiluminescence (ECL) mechanism.
Figure 3. Electrogenerated chemiluminescence (ECL) mechanism.
Molecules 26 07664 g003
Molecules 26 07664 sch001 550
Scheme 1. Luminol chemiluminescence mechanism.
Scheme 1. Luminol chemiluminescence mechanism.
Molecules 26 07664 sch001
Molecules 26 07664 sch002 550
Scheme 2. CL of cypridina luciferin, coelenterazine and their derivatives after oxidation [6,7,8,9].
Scheme 2. CL of cypridina luciferin, coelenterazine and their derivatives after oxidation [6,7,8,9].
Molecules 26 07664 sch002
Molecules 26 07664 sch003 550
Scheme 3. CL of D-luciferin hydrazine analogue catalyzed by Cu2+.
Scheme 3. CL of D-luciferin hydrazine analogue catalyzed by Cu2+.
Molecules 26 07664 sch003
Molecules 26 07664 sch004 550
Scheme 4. Proposed luminol chemiexcitation mechanism.
Scheme 4. Proposed luminol chemiexcitation mechanism.
Molecules 26 07664 sch004
Molecules 26 07664 g004 550
Figure 4. CL mechanism for monitoring hydroxylated intermediates generated on persulfate-based AOPs.
Figure 4. CL mechanism for monitoring hydroxylated intermediates generated on persulfate-based AOPs.
Molecules 26 07664 g004
Molecules 26 07664 sch005 550
Scheme 5. LHOOH intermediate proposed as the key compound for luminol’s CL.
Scheme 5. LHOOH intermediate proposed as the key compound for luminol’s CL.
Molecules 26 07664 sch005
Molecules 26 07664 g005 550
Figure 5. Free radical CL mechanism for the luminol-H2O2-Co-HAp NPs.
Figure 5. Free radical CL mechanism for the luminol-H2O2-Co-HAp NPs.
Molecules 26 07664 g005
Molecules 26 07664 g006 550
Figure 6. Proposed reaction mechanism of luminol oxidation catalyzed by FeMC6*a.
Figure 6. Proposed reaction mechanism of luminol oxidation catalyzed by FeMC6*a.
Molecules 26 07664 g006
Molecules 26 07664 g007 550
Figure 7. Cu-MOFs catalyzed luminol CL.
Figure 7. Cu-MOFs catalyzed luminol CL.
Molecules 26 07664 g007
Molecules 26 07664 g008 550
Figure 8. Substitute luminol derivatives with enhanced CL at pH 8, 10 and 12.
Figure 8. Substitute luminol derivatives with enhanced CL at pH 8, 10 and 12.
Molecules 26 07664 g008
Molecules 26 07664 sch006 550
Scheme 6. Mechanism of PO-CL between an oxalic ester and H2O2, occurring via specific base catalysis (SBS) by sodium salicylate, through the formation of (a) hydroperoxy anion, (b) monoperoxalic ester and (c) 1,2-dioxetanedione, which subsequently leads to (d) carbon dioxide and light emission.
Scheme 6. Mechanism of PO-CL between an oxalic ester and H2O2, occurring via specific base catalysis (SBS) by sodium salicylate, through the formation of (a) hydroperoxy anion, (b) monoperoxalic ester and (c) 1,2-dioxetanedione, which subsequently leads to (d) carbon dioxide and light emission.
Molecules 26 07664 sch006
Molecules 26 07664 sch007 550
Scheme 7. Reaction mechanism of TCPO with H2O2 in DME under general base catalysis by 2,6-lutidine (Lut) towards CL emission in the presence of a fluorophore.
Scheme 7. Reaction mechanism of TCPO with H2O2 in DME under general base catalysis by 2,6-lutidine (Lut) towards CL emission in the presence of a fluorophore.
Molecules 26 07664 sch007
Molecules 26 07664 sch008 550
Scheme 8. CL of 1,10-phenanthroline dioxetanes.
Scheme 8. CL of 1,10-phenanthroline dioxetanes.
Molecules 26 07664 sch008
Molecules 26 07664 g009 550
Figure 9. Bicyclic dioxetanes bearing 3-hydroxyphenyl substituted with a p-oligophenylene moiety. (a) 2-hydroxybiphenyl-4-yl; (b) 2-hydroxy-p-terphenyl-4-yl; (c) 2-hydroxy-p-quaterphenyl-4-yl; (d) 2-hydroxy-p-quinquephenyl-4-yl.
Figure 9. Bicyclic dioxetanes bearing 3-hydroxyphenyl substituted with a p-oligophenylene moiety. (a) 2-hydroxybiphenyl-4-yl; (b) 2-hydroxy-p-terphenyl-4-yl; (c) 2-hydroxy-p-quaterphenyl-4-yl; (d) 2-hydroxy-p-quinquephenyl-4-yl.
Molecules 26 07664 g009
Molecules 26 07664 g010 550
Figure 10. Chemiluminescent probe activated by 1O2 with maximum emission at 700 nm.
Figure 10. Chemiluminescent probe activated by 1O2 with maximum emission at 700 nm.
Molecules 26 07664 g010
Molecules 26 07664 sch009 550
Scheme 9. Proposed CIEEL mechanism for triggered CL of Schaap’s dioxetane probes.
Scheme 9. Proposed CIEEL mechanism for triggered CL of Schaap’s dioxetane probes.
Molecules 26 07664 sch009
Molecules 26 07664 sch010 550
Scheme 10. Modified 1,2-dioxetane probes activated by UV light.
Scheme 10. Modified 1,2-dioxetane probes activated by UV light.
Molecules 26 07664 sch010
Molecules 26 07664 sch011 550
Scheme 11. Activation mode of the self-immolative chemiluminescence prodrug Gal-A-Pept by β-galactosidase.
Scheme 11. Activation mode of the self-immolative chemiluminescence prodrug Gal-A-Pept by β-galactosidase.
Molecules 26 07664 sch011
Molecules 26 07664 g011 550
Figure 11. Carbapenemase activity monitoring based on chemiluminescent probe.
Figure 11. Carbapenemase activity monitoring based on chemiluminescent probe.
Molecules 26 07664 g011
Molecules 26 07664 sch012 550
Scheme 12. Proposed CL mechanism of acridinium derivatives.
Scheme 12. Proposed CL mechanism of acridinium derivatives.
Molecules 26 07664 sch012
Molecules 26 07664 sch013 550
Scheme 13. Proposed CL mechanism of 4-(methoxycarbonyl)phenyl-10-methyl-10λ4-2,7-dimethyl-acridine-9-carboxylates.
Scheme 13. Proposed CL mechanism of 4-(methoxycarbonyl)phenyl-10-methyl-10λ4-2,7-dimethyl-acridine-9-carboxylates.
Molecules 26 07664 sch013
Molecules 26 07664 sch014 550
Scheme 14. Intermolecular (A) and intramolecular (B) indirect CL emission modes.
Scheme 14. Intermolecular (A) and intramolecular (B) indirect CL emission modes.
Molecules 26 07664 sch014
Molecules 26 07664 g012 550
Figure 12. Indirect CL from ADLumin−1/CRANAD-3 system.
Figure 12. Indirect CL from ADLumin−1/CRANAD-3 system.
Molecules 26 07664 g012
Molecules 26 07664 g013 550
Figure 13. Indirect CL via energy transfer from activated by β-galactosidase 1,2-dioxetane to the EmeraldTM enhancer emitting at 540 nm.
Figure 13. Indirect CL via energy transfer from activated by β-galactosidase 1,2-dioxetane to the EmeraldTM enhancer emitting at 540 nm.
Molecules 26 07664 g013
Molecules 26 07664 g014 550
Figure 14. Indirect CL via energy transfer from H2S-activated 1,2-dioxetane to the Emerald IITM enhancer emitting at 535 nm.
Figure 14. Indirect CL via energy transfer from H2S-activated 1,2-dioxetane to the Emerald IITM enhancer emitting at 535 nm.
Molecules 26 07664 g014
Molecules 26 07664 g015 550
Figure 15. Indirect CL via energy transfer from 1,2-dioxetane to the Emerald IITM enhancer and subsequently to the carboxy-SNARF-1 dye (pKa = 7.4), emitting at 585 nm and 650 nm depending on the pH.
Figure 15. Indirect CL via energy transfer from 1,2-dioxetane to the Emerald IITM enhancer and subsequently to the carboxy-SNARF-1 dye (pKa = 7.4), emitting at 585 nm and 650 nm depending on the pH.
Molecules 26 07664 g015
Molecules 26 07664 g016 550
Figure 16. CL mechanism of the Au@BSA NCs-THF-CPO-Cu2+ system.
Figure 16. CL mechanism of the Au@BSA NCs-THF-CPO-Cu2+ system.
Molecules 26 07664 g016
Molecules 26 07664 g017 550
Figure 17. CL dynamic therapy based on L012/H2O2 catalyzed by FeDP-Pdots.
Figure 17. CL dynamic therapy based on L012/H2O2 catalyzed by FeDP-Pdots.
Molecules 26 07664 g017
Molecules 26 07664 g018 550
Figure 18. CL induced cationic polymerization by using sulfonium salt as a photoinitiator.
Figure 18. CL induced cationic polymerization by using sulfonium salt as a photoinitiator.
Molecules 26 07664 g018
Molecules 26 07664 g019 550
Figure 19. Design and mechanism of ratio-pHCL-1 (CIEEL).
Figure 19. Design and mechanism of ratio-pHCL-1 (CIEEL).
Molecules 26 07664 g019
Molecules 26 07664 sch015 550
Scheme 15. Chemical structures of chemiluminescent probes emitting light at 610 nm.
Scheme 15. Chemical structures of chemiluminescent probes emitting light at 610 nm.
Molecules 26 07664 sch015
Molecules 26 07664 g020 550
Figure 20. Chemiluminescence activation mechanism of a Glow-CRET system.
Figure 20. Chemiluminescence activation mechanism of a Glow-CRET system.
Molecules 26 07664 g020
Molecules 26 07664 sch016 550
Scheme 16. 1O2 chemiluminescence with emissions at 633 nm, 703 nm and 1270 nm.
Scheme 16. 1O2 chemiluminescence with emissions at 633 nm, 703 nm and 1270 nm.
Molecules 26 07664 sch016
Molecules 26 07664 g021 550
Figure 21. The CL-induced 1O2 production (A), the CL emission produced by the radiative decay of singlet oxygen (B) and CL emission after the activation of a probe molecule by 1O2 (C).
Figure 21. The CL-induced 1O2 production (A), the CL emission produced by the radiative decay of singlet oxygen (B) and CL emission after the activation of a probe molecule by 1O2 (C).
Molecules 26 07664 g021
Molecules 26 07664 sch017 550
Scheme 17. The CL-induced singlet oxygen production for the oxidation of 1-phenylcyclohexene in “green” solvent ethyl acetate.
Scheme 17. The CL-induced singlet oxygen production for the oxidation of 1-phenylcyclohexene in “green” solvent ethyl acetate.
Molecules 26 07664 sch017
Table
Table 1. Types of luminescence based on different activation mode.
Table 1. Types of luminescence based on different activation mode.
Type of LuminescenceActivation ModeReferences
Photoluminescence (PL)Photoexcitation[37,38,39]
Chemiluminescence (CL) and Bioluminescence (BL)Chemiexcitation[40,41]
Electrochemiluminescence (ECL) Electrochemical Excitation[42]
Table
Table 2. Summary of recent scaffolds, systems and applications based on direct chemiluminescence [54].
Table 2. Summary of recent scaffolds, systems and applications based on direct chemiluminescence [54].
ScaffoldSystemApplicationsReferences
LuminolWithout System, Cobalt-Doped Hydroxyapatite Nanoparticles, Cu-Metal-Organic FrameworksMonitoring of Advanced Oxidation Processes, Sensing, H2O2 and O2●– Detection[55,56,57,58,59]
ADLumin-1 Amyloid Beta (Aβ) Species Probe[60]
DioxetanePrecursor of Dioxetane Containing the Dicyanomethylchromone Moiety, Functional Self-immolative Molecular Scaffolds1O2 Detection in vitro and in vivo, Monitoring of β-Galactosidase Activity—Drug Uncaging, Carbapenemase Activity, Enzymatic Activity of Prostate Specific Antigen (PSA)[54,61,62,63,64]
Table
Table 3. Summary of recent scaffolds, systems and applications based on intermolecular indirect chemiluminescence.
Table 3. Summary of recent scaffolds, systems and applications based on intermolecular indirect chemiluminescence.
ScaffoldSystemApplicationsReferences
ADLumin-1CRANAD-3Aβ Species Probe[60]
LuminolChlorine6 Containing QDs Polymeric NPs, Fe(III) Deuteroporphyrin IX Chloride NPs, CdSeTe Core QDsH2O2 Imaging and Therapy[116,117,118]
Peroxyoxalate9,10-DiphenylanthraceneCationic Polymerization[119]
DioxetaneEmeraldTM and Emerald IITM Enhancers, Carboxy-SNARF-1 DyeImaging of β-Galactosidase and Nitroreductase Activities, H2S, Ratiometric pH[116,120,121,122]
Table
Table 4. Summary of imaging, sensing and therapy approaches based on intramolecular indirect chemiluminescence.
Table 4. Summary of imaging, sensing and therapy approaches based on intramolecular indirect chemiluminescence.
ScaffoldSystemApplicationsReferences
DioxetaneMolecular pH-Sensitive Carbofluorescein Probe
Precursor of Dioxetane		Ratiometric pH Imaging in Live Animals[123]
Cypridina LuciferinSulforhodamine 101O2•− Detection[124]
Phenoxy-Dioxetane 7-HydroxycoumarinFRET QuencherMonitoring of Matrix Metalloproteinase Activity[125]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Tzani, M.A.; Gioftsidou, D.K.; Kallitsakis, M.G.; Pliatsios, N.V.; Kalogiouri, N.P.; Angaridis, P.A.; Lykakis, I.N.; Terzidis, M.A. Direct and Indirect Chemiluminescence: Reactions, Mechanisms and Challenges. Molecules 2021, 26, 7664. https://doi.org/10.3390/molecules26247664

AMA Style

Tzani MA, Gioftsidou DK, Kallitsakis MG, Pliatsios NV, Kalogiouri NP, Angaridis PA, Lykakis IN, Terzidis MA. Direct and Indirect Chemiluminescence: Reactions, Mechanisms and Challenges. Molecules. 2021; 26(24):7664. https://doi.org/10.3390/molecules26247664

Chicago/Turabian Style

Tzani, Marina A., Dimitra K. Gioftsidou, Michael G. Kallitsakis, Nikolaos V. Pliatsios, Natasa P. Kalogiouri, Panagiotis A. Angaridis, Ioannis N. Lykakis, and Michael A. Terzidis. 2021. "Direct and Indirect Chemiluminescence: Reactions, Mechanisms and Challenges" Molecules 26, no. 24: 7664. https://doi.org/10.3390/molecules26247664

APA Style

Tzani, M. A., Gioftsidou, D. K., Kallitsakis, M. G., Pliatsios, N. V., Kalogiouri, N. P., Angaridis, P. A., Lykakis, I. N., & Terzidis, M. A. (2021). Direct and Indirect Chemiluminescence: Reactions, Mechanisms and Challenges. Molecules, 26(24), 7664. https://doi.org/10.3390/molecules26247664

Article Metrics

Back to TopTop